Senti Biosciences Holdings, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
0.1721
-0.0449 (-20.69%)
Oct 30, 2026, 1:23 PM EDT - Market open
SNTI Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.06 | 0.02 | - | 2.56 | 4.29 | 2.76 | |
Revenue Growth | - | - | - | -40.25% | 55.23% | 387.81% |
Cost of Revenue | 31.32 | 37.59 | 34.36 | 32.15 | 28.15 | 21.96 |
Gross Profit | -31.27 | -37.56 | -34.36 | -29.59 | -23.86 | -19.2 |
Selling, General & Admin | 22.05 | 20.74 | 19.92 | 34.85 | 38.23 | 21.25 |
Operating Expenses | 22.05 | 20.74 | 19.92 | 34.85 | 38.23 | 21.25 |
Operating Income | -53.32 | -58.3 | -54.28 | -64.44 | -62.08 | -40.45 |
Interest & Investment Income | 0.42 | 0.93 | 0.95 | 2.86 | 1.7 | 0.01 |
Other Non Operating Income (Expenses) | 1.51 | 0.99 | 18.07 | 3.3 | -0.03 | -0.12 |
EBT Excluding Unusual Items | -51.39 | -56.39 | -35.26 | -58.28 | -60.42 | -40.56 |
Asset Writedown | -5.05 | -5.05 | -0.31 | -25.96 | - | -0.02 |
Other Unusual Items | 6.88 | - | -17.22 | 0.83 | 10.75 | -14.74 |
Pretax Income | -49.56 | -61.44 | -52.79 | -83.41 | -49.67 | -55.32 |
Earnings From Continuing Operations | -49.56 | -61.44 | -52.79 | -83.41 | -49.67 | -55.32 |
Earnings From Discontinued Operations | - | - | - | 12.35 | -8.55 | - |
Net Income | -49.56 | -61.44 | -52.79 | -71.06 | -58.21 | -55.32 |
Preferred Dividends & Other Adjustments | - | - | 2.52 | - | - | - |
Net Income to Common | -49.56 | -61.44 | -55.31 | -71.06 | -58.21 | -55.32 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 29 | 22 | 5 | 4 | 3 | 0 |
Shares Outstanding (Diluted) | 29 | 22 | 5 | 4 | 3 | 0 |
Shares Change | 155.08% | 389.20% | 3.58% | 69.93% | 796.58% | -78.99% |
EPS (Basic) | -1.71 | -2.73 | -12.03 | -16.01 | -22.29 | -189.95 |
EPS (Diluted) | -1.71 | -2.73 | -12.03 | -16.01 | -22.29 | -189.95 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -38.05 | -43.64 | -41.42 | -64.43 | -76.27 | -40.18 |
Free Cash Flow Per Share | -1.31 | -1.94 | -9.01 | -14.52 | -29.21 | -137.96 |
Operating Margin | -96943.64% | -265018.18% | - | -2516.28% | -1448.53% | -1464.90% |
Profit Margin | -90116.36% | -279263.64% | - | -2774.62% | -1358.14% | -2003.59% |
Free Cash Flow Margin | -69183.64% | -198363.64% | - | -2515.93% | -1779.51% | -1455.20% |
EBITDA | -50.17 | -54.67 | -50.44 | -60.88 | -60.69 | -39.68 |
D&A For EBITDA | 3.15 | 3.64 | 3.84 | 3.56 | 1.4 | 0.77 |
EBIT | -53.32 | -58.3 | -54.28 | -64.44 | -62.08 | -40.45 |
Revenue as Reported | - | - | - | 2.56 | 4.29 | 2.76 |